These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 15080829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R, Saritzali G, Canakcioglu S.
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler NN, Barlan IB.
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
    Mungan D, Misirligil Z, Gürbüz L.
    Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y, Sekerel BE, Kalayci O, Adalioğlu G, Tuncer A.
    J Investig Allergol Clin Immunol; 1998 May; 8(2):98-104. PubMed ID: 9615303
    [Abstract] [Full Text] [Related]

  • 14. [Preventive immunotherapy].
    Boquete M, Carballada F, Expósito F, González A.
    Allergol Immunopathol (Madr); 2000 May; 28(3):89-93. PubMed ID: 10867376
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
    Riechelmann H, Schmutzhard J, van der Werf JF, Distler A, Kleinjans HA.
    Am J Rhinol Allergy; 2010 May; 24(5):e104-9. PubMed ID: 21244725
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
    Tari MG, Mancino M, Monti G.
    Allergol Immunopathol (Madr); 1990 May; 18(5):277-84. PubMed ID: 2097894
    [Abstract] [Full Text] [Related]

  • 19. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.
    Kim ST, Han DH, Moon IJ, Lee CH, Min YG, Rhee CS.
    Am J Rhinol Allergy; 2010 May; 24(4):271-5. PubMed ID: 20819465
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D, Keck T, Riechelmann H.
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.